The p66Shc Redox Protein and the Emerging Complications of Diabetes
Authors:
- Giuseppina BiondiGBGiuseppina Biondi
- Nicola MarranoNicola Marrano
- Anna BorrelliABAnna Borrelli
- Martina RellaMRMartina Rella
- Rossella D’oriaRDRossella D’oria
- Valentina Annamaria GenchiVGValentina Annamaria Genchi
- Cristina CaccioppoliCCCristina Caccioppoli
- Angelo CignarelliAngelo Cignarelli
- Sebastio PerriniSPSebastio Perrini
- Luigi LaviolaLLLuigi Laviola
- Francesco GiorginoFrancesco Giorgino
- Annalisa NatalicchioAnnalisa Natalicchio
Open Access
- 20 December 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (1) , 108
Abstract
Diabetes mellitus is a chronic metabolic disease, the prevalence of which is constantly increasing worldwide. It is often burdened by disabling comorbidities that reduce the quality and expectancy of life of the affected individuals. The traditional complications of diabetes are generally described as macrovascular complications (e.g., coronary heart disease, peripheral arterial disease, and stroke), and microvascular complications (e.g., diabetic kidney disease, retinopathy, and neuropathy). Recently, due to advances in diabetes management and the increased life expectancy of diabetic patients, a strong correlation between diabetes and other pathological conditions (such as liver diseases, cancer, neurodegenerative diseases, cognitive impairments, and sleep disorders) has emerged. Therefore, these comorbidities have been proposed as emerging complications of diabetes. P66Shc is a redox protein that plays a role in oxidative stress, apoptosis, glucose metabolism, and cellular aging. It can be regulated by various stressful stimuli typical of the diabetic milieu and is involved in various types of organ and tissue damage under diabetic conditions. Although its role in the pathogenesis of diabetes remains controversial, there is strong evidence regarding the involvement of p66Shc in the traditional complications of diabetes. In this review, we will summarize the evidence supporting the role of p66Shc in the pathogenesis of diabetes and its complications, focusing for the first time on the emerging complications of diabetes.Keywords
Funding Information
- National Center for Gene ‘Therapy and Drugs based on RNA Technology’ (CN00000041, H93C22000430007)
- European Union-NextGenerationEU—PNRR MUR- M4C2- Investimento 1.4—CUP UNIBA (CN00000041, H93C22000430007)
This publication has 127 references indexed in Scilit:
- Role of p66shc in Renal Toxicity of Oleic AcidAmerican Journal of Nephrology, 2013
- The P66Shc/Mitochondrial Permeability Transition Pore Pathway Determines NeurodegenerationOxidative Medicine and Cellular Longevity, 2013
- Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66 ShcProceedings of the National Academy of Sciences, 2012
- p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and miceJournal of Hepatology, 2012
- The ShcA SH2 domain engages a 14-3-3/PI3′K signaling complex and promotes breast cancer cell survivalOncogene, 2012
- Oxidative stress alters the regulatory control of p66Shc and Akt in PINK1 deficient cellsBiochemical and Biophysical Research Communications, 2010
- Mammalian life-span determinant p66 shcA mediates obesity-induced insulin resistanceProceedings of the National Academy of Sciences, 2010
- The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound HealingDiabetes, 2010
- Hyperglycemia-Induced p66shc Inhibits Insulin-Like Growth Factor I-Dependent Cell Survival via Impairment of Src Kinase-Mediated Phosphoinositide-3 Kinase/AKT Activation in Vascular Smooth Muscle CellsEndocrinology, 2010
- Genetic deletion of p66 Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stressProceedings of the National Academy of Sciences, 2007